News

The Former CEO of 23andMe Is Buying the Company Back After All
Then, a company named Regeneron announced they would buy the company, and would “prioritize [consumer data's] privacy, ...
River Journal Online14h
Regeneron Outbid in Effort to Acquire 23andMe
Regeneron Pharmaceuticals was outbid in its effort to buy 23andMe by a nonprofit led by the bankrupt genetics testing company’s co-founder. California-based TTAM Research Institute, led by Anne ...
Anne Wojcicki's bid to buy back 23andMe may not end a legal fight over DNA customer data
Anne Wojcicki’s winning bid to reclaim control of 23andMe doesn’t necessarily end the fight over what happens to the DNA of ...
BioSpace1d
Regeneron Backs Off 23andMe, Losing Bid to Former CEO
Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...
GovInfoSecurity1d
23andMe's Co-Founder to Buy Company; Makes Privacy Pledge
TTAM Research Institute - 23andMe's co-founder and former CEO Anne Wojcicki's new company - is the winner in a final round of ...
BioPharma Dive19h
FDA clears CSL’s swelling disease drug; Regeneron loses 23andMe auction
The agency cleared CSL’s hereditary angioedema drug days after “resource constraints” delayed a rival medicine. Elsewhere, ...
Congress Demands Answers on Data Privacy Ahead of 23andMe Sale
House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer ...